Trial Design

Latest News

Boehringer Ingelheim, Gubra Initiate Phase I Clinical Trial for BI 3034701, a Potential Obesity Treatment

July 3rd 2024

Clinical trial for BI 3034701 is expected to evaluate the safety, tolerability, and pharmacokinetics in healthy men and overweight or obese individuals aged 18-55 years old.

Phase III Vivacity-MG3 Trial Demonstrates Superiority of Nipocalimab Over Placebo in Treating Patients with Generalized Myasthenia Gravis

By Don Tracy, Associate Editor

July 1st 2024

Expanding Conceptual Model of Disease into Conceptual Model of Patient Experience for Designing, Interpreting Medication Effects

By Reaney M, Bruce R, Kelly K, Hughes L.

June 28th 2024

Image credit: wladimir1804 | stock.adobe.com

Clinical Trials in Indonesia: Challenges and Opportunities for Industry Sponsors

By Lena Low; Martin Lim; Terttu Haring; Serena Chan; David Gebbo; Lucia Rizka Andalucia; Roy Himawan; Indri Rooslamiati; Dona Arlinda

June 17th 2024

Aligning Patient Burden with Planetary Burden

By Michael Cohen
Robyn Owens

June 7th 2024

More News

Digital Stethoscope for At-Home ECG and More

June 29th 2023

Eko Health developed the device, which has received 501(k) clearance from the FDA.

eCOA IRT eConsent: Simplifying user experience and driving process efficiencies through integration and automation

IQVIA

June 5th 2023

Webinar Date/Time: Thursday, June 22nd, 2023 at 9am EDT | 6pm PDT | 2pm BST | 3pm CEST

Measured Momentum: Digital Biomarkers and Clinical Trials

Christine Bahls

May 15th 2023

‘No longer just a cool technology,’ efforts to validate these signals are evolving.

Breathing New Life into Respiratory Clinical Trials with Digital Biomarkers

Elena Izmailova, PhD;Victoria Hunter

May 10th 2023

Increased data output from the use of devices can accelerate trials for this therapeutic area in need of new therapies.

Easing the Clinical Trial Technology Burden on Patients and Sites

Allison Barnard

April 7th 2023

Innovative Tools for Patient-Centric Clinical Trial Design: Examples and Applications from Eli Lilly

Moe Alsumidaie

March 24th 2023

Presentation at SCOPE 2023 highlights tools such as interactive schedules and benchmarked data which can increase patient centricity.

How to Use Hidden Data Flow to Accelerate Your Trials in an Inflation Reduction Act Environment

Clinical Trials Moving From Site to Home—Lessons Learned from Digital Health Technologies

IQVIA

March 23rd 2023

Webinar Date/Time: Tue, May 9, 2023 11:00 AM EDT

Crowdsource UAT: An Opportunity for Future Validation

IQVIA

March 16th 2023

Webinar Date/Time: Option 1: Thursday, April 13th, 2023 at 9am EDT | 2pm BST | 3pm CEST Option 2: Thursday, April 13th, 2023 at 2pm EDT | 11am PDT | 7pm BST

Connecting real-world data and domain expertise to enhance trial design and planning

IQVIA

March 16th 2023

Webinar Date/Time: Thu, May 4, 2023 10:00 AM EDT

Insights from Eli Lilly’s TRAILBLAZER-ALZ Program

Moe Alsumidaie

March 16th 2023

John R. Sims, senior vice president and head of global development, and Dawn A. Brooks, director of clinical development; both with Eli Lilly discuss the design of the TRAILBLAZER-ALZ program.

How DCT Technology Can Enable Follow-up Clinical Studies

Jane Myles

March 8th 2023

Research can reveal vital information about treatments in the long run.

The Impact of Trial Design on Interest by Race and Ethnicity

Denise Messer

March 3rd 2023

Survey examines trial enrollment motivation among diverse populations.

Ancillaries are simple, right? Think again.

Myonex

March 2nd 2023

Webinar Date/Time: Wednesday, March 29, 2023 at 11am ET |10 am CT | 8am PT

Accelerate Clinical Trial Success with Genomics Experts

InformedDNA

February 13th 2023

Webinar Date/Time: Thu, Mar 2, 2023 1:00 PM EST

How to Supercharge Real World Evidence Generation in Phase IV Trials

Medable

February 9th 2023

Webinar Date/Time: Thu, Mar 16, 2023 11:00 AM EDT

Shifting Data Closer to the Patient

IQVIA

February 6th 2023

Webinar Date/Time: Thursday, March 30th, 2023 at 10am EDT|7am PDT|3pm BST|4pm CEST

At-home Self-collection of Blood Specimens for Safety Lab Testing in Clinical Trials via the Tasso+ Device

Chuck Drucker;Charlie Fix;Patrice Hugo, PhD;Julia Beck, PhD;Steven Lobel, PhD, D-ABMLI, MBA, FACB;John Corcoran;Viren Patel, PhD

February 1st 2023

Laboratory services organization focuses on easing patient and site burden with improved collection device.

How to Make Your Rare Disease Trials More Patient and Site-Centric

Advanced Clinical

February 1st 2023

Webinar Date/Time: Thu, Mar 9, 2023 11:00 AM EST

Applied Adaptive Design Using Subgroup Identification & Machine Learning

IQVIA

January 17th 2023

Webinar Date/Time: Tue, Mar 14, 2023 11:00 AM EDT

Revolutionizing the Modern Trial Strategy

IQVIA

January 12th 2023

Webinar Date/Time: Tuesday, February 14th, 2023 at 10am EST|7am PST|3pm GMT|4pm CET

Clinical Operations and DCT Tech Merge for Better Patient Oversight

Moe Alsumidaie

January 6th 2023

Gillian Livock, SVP & general manager, customer engagement at Medable and Noolie Gregory, VP of DCT operations at Syneos Health discuss how combining technology with clinical operations delivers better data and clinical trial patient oversight.

How Mobile Nursing is Evolving to Meet the Stringent Demands of Today’s Decentralized Clinical Trials

PCM Trials

January 4th 2023

Webinar Date/Time: Thu, Jan 26, 2023 11:00 AM EST

Decentralized Guidance Is the Best That Europe Can Do for Decentralized Clinical Trials

Peter O'Donnell, ACT's Brussels Correspondent

December 22nd 2022

Despite agreement on recommendations between European regulators, DCT unclarity remains.

The Keys to eCOA Implementation Success

IQVIA

December 16th 2022

Webinar Date/Time: Tuesday, January 24th, 2023 at 11am EST|8am PST|4pm GMT|5pm CET

How Clinical Trials Can Thrive in the Digital Era

Applied Clinical Trials Editorial Staff

November 22nd 2022

The Digital Medicine Society (DiMe) CEO Jennifer Goldsack and Takeda’s Head of Digital Health Sciences, Data Sciences Institute Shoibal Datta describe the current landscape of digitized clinical trials and the decisions needed to fully utilize their potential.